Head of the department- hematologist- Maya V. Solovieva, Candidate of Medical Sciences, hematologist of the highest qualification category
The department functions as part of the Division of Chemotherapy of Paraproteinemic Hemoblastosis.
The department, as an independent clinical unit, was organized in 2022. The need to open this department as part of the Division of Chemotherapy of Paraproteinemic Hemoblastosis was dictated by the increased need for diagnostic and therapeutic measures for patients with various plasma cell tumors in outpatient settings. Doctors working in the day hospital participate in rounds and are on duty in the round-the-clock Department of Hematology and Chemotherapy of Paraproteinemic Hemoblastosis with Bone Marrow and Hematopoietic Stem Cell Transplantation Unit, which provides in-depth knowledge of the course of the disease in patients with plasma cell tumors receiving intensive antitumor treatment. Close cooperation with the department's round-the-clock hospitals makes it possible to maintain continuity in patient therapy.
List of diseases and syndromes with which patients can be referred for examination, differential diagnosis and treatment:
- symptomatic multiple myeloma;
- smoldering myeloma;
- monoclonal gammopathy of unspecified significance;
- monoclonal gammopathy of clinical (organ) significance;
- plasma cell leukemia;
- solitary plasmacytoma;
- plasmablastic lymphoma;
- Waldenstrom's macroglobulinemia;
- AL-amyloidosis;
- POEMS-syndrome;
- heavy chain deposition disease (HCDD)
- Heavy-chain deposition disease;
- other rare forms of diseases occurring with the secretion of pathological immunoglobulins.
The Day Hospital of Hematology and Chemotherapy of Plasma Cell Tumors is a form of medical care in which the patient does not need to permanently stay at the medical institution but can come to perform specific diagnostic and therapeutic procedures. Treatment in a day hospital is carried out under the supervision of a qualified hematologist, who draws up a plan of therapeutic and diagnostic measures, determines the duration of therapy and the dates of attendance. If necessary, consultations of doctors of other specialties are held and medical consultations are organized.
The Day Hospital of Hematology and Chemotherapy of Plasma Cell Tumors:
- provides high-quality, high-tech medical care
- conducts systemic antitumor therapy
- implements various treatment regimens with targeted drugs with a biological mechanism of antitumor action, subcutaneous, intravenous administration of drugs
- evaluates the effectiveness of the treatment (blood and urine tests, bone marrow puncture, trepanobiopsy)
- provides daily observation by a doctor, individual approach to each patient, convenience of stay
- allows the opportunity for the patient to participate in Russian and international clinical trials of the latest medicines
STAFF
Alina A. Kreizman- hematologist
Eleonora A. Makunina- hematologist
Anastasia A. Dimitrenko- senior nurse
